Urine test may spare bladder cancer patients from frequent scopes

NCT ID NCT07511517

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a urine test called BladMetrix to see if it can detect bladder cancer returning after surgery. 500 adults with non-muscle invasive bladder cancer will provide urine samples during routine follow-up visits over 2 years. The test's accuracy will be compared to standard cystoscopy (camera exam) and urine cytology. If it works well, it could reduce the need for invasive camera exams.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

BladMetrix urine test

What this could lead to

If successful, this urine test could reduce the need for frequent camera exams (cystoscopies) and allow more personalized follow-up schedules for people with bladder cancer.

What could go wrong

This is an observational study, not a treatment trial. The test is still being compared to standard methods, and it may not be accurate enough to replace cystoscopy. Results are early and need further validation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for URINARY BLADDER NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

allergic disease bladder transitional cell carcinoma carcinoma non-invasive bladder urothelial carcinoma Non-Muscle Invasive Bladder Neoplasms urinary bladder neoplasm Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Akershus University Hospital (Ahus)

    Lørenskog, Norway

  • Haukeland University Hospital

    Bergen, Norway

  • Oslo University Hospital - Aker

    Oslo, Norway

  • St. Olavs Hospital - Trondheim University Hospital

    Trondheim, Norway

  • University Hospital of North Norway (UNN)

    Tromsø, Norway

  • Vestfold Hospital Trust (SiV)

    Tønsberg, Norway